» Go to news main
Dalhousie receives $5.1 million investment in health research
Eight researchers from Dalhousie University are the recipients of over $5 million in funding from the Government of Canada for their innovative health research.
The funding, which is provided by the Canadian Institutes of Health Research (CIHR) project grants, will help Dal’s world-class researchers study a wide range of topics, including: cancer therapy and gene editing; low testosterone and its impact on the heart; pharmaceutical safety and transparency; insulin resistance and heart muscle damage; neurodevelopmental disorders; innate immune memory; more effective breast cancer treatments; and alternative therapies for bacterial infections.
The announcement was made on Wednesday, January 24 at Memorial University of Newfoundland. In total, 512 research projects from across the country will receive $372 million in funding.
Successfully funded researchers:
- Graham Dellaire, Departments of Pathology and Biochemistry & Molecular Biology
- Susan Howlett, Department of Pharmacology
- Matthew Herder, Health Law Institute and Department of Pharmacology
- Petra Kienesberger, Department of Biochemistry & Molecular Biology
- Angelo Iulianella, Department of Medical Neuroscience
- Andrew Makrigiannis, Department of Microbiology and Immunology
- Kirill Rosen, Department of Biochemistry & Molecular Biology
- Xianping Dong, Department of Physiology and Biophysics
Read more on Dal News.
- A night to remember: Dal Med 150th celebration gala
- Richard Goldbloom: founding father of modern pediatrics
- Newly‑launched Institute of Genetics a first for Atlantic Canada
- Dal Med appoints public health physician to "serving and engaging society" post
- Molly Appeal‑funded equipment attracts immunity scientist to Dal
- Dr. Nuala Kenny: a pioneer of Canadian bioethics
- Four Psychiatry faculty members recognized at industry event
- Dal oncology resident finds high rates of burnout among Canadian peers